The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

February 2012

Volume 52, Issue 2

Pages 128–281

  1. Review

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Drug Interactions
    7. Pharmacovigilance
    8. Brief Reports
    9. Letter to the Editor
  2. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Drug Interactions
    7. Pharmacovigilance
    8. Brief Reports
    9. Letter to the Editor
    1. Single-Dose Tolerability, Pharmacokinetics, and Pharmacodynamics of Etamicastat (BIA 5–453), a New Dopamine β-Hydroxylase Inhibitor, in Healthy Subjects (pages 156–170)

      Dr José Francisco Rocha, Dr Manuel Vaz-Da-Silva, Dr Teresa Nunes, Dr Bruno Igreja, Dr Ana I. Loureiro, Dr Maria João Bonifácio, Dr Lyndon C. Wright, Dr Amílcar Falcão, Dr Luis Almeida and Dr Patricio Soares-Da-Silva

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010390805

    2. Combined Administration of Quinidine and Propafenone for Atrial Fibrillation: The CAQ-PAF Study (pages 171–179)

      Dr Gilles E. O'Hara, Dr François Philippon, Dr Marcel Gilbert, Dr Jean Champagne, Dr Véronique Michaud, Ms Lyne Charbonneau, Dr Guylaine Pruneau, Dr Bettina A. Hamelin, Dr Peter Geelen and Dr Jacques Turgeon

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011399574

  3. Pharmacokinetics

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Drug Interactions
    7. Pharmacovigilance
    8. Brief Reports
    9. Letter to the Editor
    1. Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies (pages 180–194)

      Ms Huali Wu, Dr Ramesh K. Ramanathan, Dr Beth A. Zamboni, Ms Sandra Strychor, Dr Suresh Ramalingam, Dr Robert P. Edwards, Dr David M. Friedland, Dr Ronald G. Stoller, Dr Chandra P. Belani, Dr Lauren J. Maruca, Dr Yung-Jue Bang and Ms William C. Zamboni

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010394851

    2. Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers (pages 195–203)

      SeungHwan Lee, Bo-Hyung Kim, Won-Seok Nam, Seo Hyun Yoon, Joo-Youn Cho, Sang-Goo Shin, In-Jin Jang and Kyung-Sang Yu

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010395510

    3. Model-Based Evaluation of Similarity in Pharmacokinetics of Two Formulations of the Blood-Derived Plasma Product C1 Esterase Inhibitor (pages 204–213)

      Dr Ron J. Keizer, Dr Ilona Kleine Budde, Dr Paul F. W. Sprengers, Dr M. Levi, Dr Jos H. Beijnen and Dr Alwin D. R. Huitema

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010394446

    4. Comparative Bioavailability of a Premixed, Ready-to-Use Formulation of Intravenous Amiodarone With Traditional Admixture in Healthy Subjects (pages 214–221)

      Drs Daniel J. Cushing, Dr Michael P. Adams, Warren D. Cooper, Bushra Agha and Mr Paul F. Souney

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010395938

  4. Pharmacodynamics

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Drug Interactions
    7. Pharmacovigilance
    8. Brief Reports
    9. Letter to the Editor
    1. Evaluation of Eslicarbazepine Acetate on Cardiac Repolarization in a Thorough QT/QTc Study (pages 222–233)

      Dr Manuel Vaz-Da-Silva, Dr Teresa Nunes, Dr Luis Almeida, Dr Maria J. Gutierrez, Dr Jeffrey S. Litwin and Dr Patrício Soares-Da-Silva

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010391789

    2. Lack of Association of OPRM1 and ABCB1 Single-Nucleotide Polymorphisms to Oxycodone Response in Postoperative Pain (pages 234–242)

      Dr Stine T. Zwisler, Dr Thomas P. Enggaard, Dr Soeren Mikkelsen, Dr Céline Verstuyft, Dr Laurent Becquemont, Dr Soeren H. Sindrup and Dr Kim Brosen

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010397729

  5. Drug Interactions

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Drug Interactions
    7. Pharmacovigilance
    8. Brief Reports
    9. Letter to the Editor
    1. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin (pages 243–250)

      Dr Joachim Stangier, Ms Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth, Dr Kathrin Reseski and Dr Thomas Körnicke

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010393342

    2. Absence of Pharmacokinetic Interaction Between Roflumilast and Digoxin in Healthy Adults (pages 251–257)

      Dr Gabriel Eckermann, Dr Gezim Lahu, Dr Nassr Nassr and Dr Thomas D. Bethke

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010389467

  6. Pharmacovigilance

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Drug Interactions
    7. Pharmacovigilance
    8. Brief Reports
    9. Letter to the Editor
    1. Drug Burden Index and Beers Criteria: Impact on Functional Outcomes in Older People Living in Self-Care Retirement Villages (pages 258–265)

      Dr Danijela Gnjidic, Dr David G. Le Couteur, Dr Darrell R. Abernethy and Dr Sarah N. Hilmer

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010395591

  7. Brief Reports

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Drug Interactions
    7. Pharmacovigilance
    8. Brief Reports
    9. Letter to the Editor
    1. A Case of Severe Hypothermia Following Single-Dose Administration of Olanzapine: A Case Report (pages 266–268)

      Peter Kreuzer, Michael Landgrebe, Göran Hajak, Sarah Julia Burger and Berthold Langguth

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010396712

    2. Life-Threatening Hypoglycemia With Moxifloxacin in a Dialysis Patient (pages 269–271)

      Dr Rajan Kapoor, Dr David Blum, Dr Anu Batra, Dr Nidhi Varma, Dr Kameswari Lakshmi, Dr Prasanta Basak and Dr Stephen Jesmajian

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010391788

    3. Dapsone-Associated Methemoglobinemia in a Patient With Slow NAT2*5B Haplotype and Impaired Cytochrome b5 Reductase Activity (pages 272–278)

      Dr Mahmoud Abouraya, Dr James C. Sacco, Dr Kristie Hayes, Dr Sajeve Thomas, Dr Craig S. Kitchens and Dr Lauren A. Trepanier

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010393343

  8. Letter to the Editor

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Drug Interactions
    7. Pharmacovigilance
    8. Brief Reports
    9. Letter to the Editor
    1. Human Intravenous Immunoglobulin—Induced Aseptic Meningitis: A Case Report (pages 279–281)

      Dr A. Chaabane, Dr A. Hamzaoui, Dr K. Aouam, Dr R. Klai, Dr N. Ben Fredj, Dr N. A. Boughattas and Dr S. Mahjoub

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270010394183

SEARCH

SEARCH BY CITATION